Windlas Biotech Ltd: Stock Analysis & Fundamentals

Updated this week

Windlas Biotech Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 24.2. ROE: 12.8%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

👔Promoter stake down 0.5% this quarter

🌐FII stake decreased 0.9% this quarter

🏛️DII accumulation — stake up 1.9%

Key Numbers

Current Price

₹765

Dividend Yield

0.76%

Market Cap

1.6K Cr

Valuation

N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd

Average

+15.9%

Acutaas Chemicals Ltd

SMS Pharmaceuticals Ltd

Average • 12w streak

+37.7%

← Back to Pharma - API & CRAMS Dashboard

Frequently Asked Questions: Windlas Biotech Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Windlas Biotech Ltd's latest quarterly results?

Windlas Biotech Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -6.2%
Revenue Growth YoY: +19.5%
Operating Margin: 10.0%

What is Windlas Biotech Ltd's current PE ratio?

Windlas Biotech Ltd's current PE ratio is 24.2x.

Current PE: 24.2x
Market Cap: 1.6K Cr
Dividend Yield: 0.76%

What is Windlas Biotech Ltd's price-to-book ratio?

Windlas Biotech Ltd's price-to-book ratio is 3.0x.

Price-to-Book (P/B): 3.0x
Book Value per Share: ₹253
Current Price: ₹765

Is Windlas Biotech Ltd a fundamentally strong company?

Windlas Biotech Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 17.0%

Is Windlas Biotech Ltd debt free?

Windlas Biotech Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹33 Cr

What is Windlas Biotech Ltd's return on equity (ROE) and ROCE?

Windlas Biotech Ltd's return ratios over recent years

FY2023: ROCE 14.0%
FY2024: ROCE 18.0%
FY2025: ROCE 17.0%

Is Windlas Biotech Ltd's cash flow positive?

Windlas Biotech Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹68 Cr
Free Cash Flow (FCF): ₹-6 Cr
CFO/PAT Ratio: 111% (strong cash conversion)

What is Windlas Biotech Ltd's dividend yield?

Windlas Biotech Ltd's current dividend yield is 0.76%.

Dividend Yield: 0.76%
Current Price: ₹765

Who holds Windlas Biotech Ltd shares — promoters, FII, DII?

Windlas Biotech Ltd's shareholding pattern (Dec 2025)

Promoters: 62.0%
FII (Foreign): 0.9%
DII (Domestic): 11.4%
Public: 25.6%

Is promoter holding increasing or decreasing in Windlas Biotech Ltd?

Windlas Biotech Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 62.0% (Dec 2025)
Previous Quarter: 62.0% (Sep 2025)
Change: 0.00% (stable)

Is Windlas Biotech Ltd a new momentum entry or an established outperformer?

Windlas Biotech Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Windlas Biotech Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Windlas Biotech Ltd may be worth studying

Cash flow is positive — CFO ₹68 Cr

What is the investment thesis for Windlas Biotech Ltd?

Windlas Biotech Ltd investment thesis summary:

What is the future outlook for Windlas Biotech Ltd?

Windlas Biotech Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.